Publications

Apel, M. et al. (2013) Integrated Clinical Scale Manufacturing System for Cellular Products Derived by Magnetic Cell Separation, Centrifugation and Cell Culture. Chemie Ingenieur Technik 85(I-2): 103–110.
Read paper

Hadenfeld, M. et al. (2016) Automatisierung für die personalisierte Krebstherapie. Biospektrum 22: 496–98.
Read paper

Kaiser, A.D. et al. (2015) Towards a commercial process for the manufacture of genetically modified T cells for therapy. Cancer Gene Ther 22(2): 72–78.
Read paper

Kloss, S. et al. (2017) Optimization of human NK cell manufacturing: Fully automated separation, improved ex vivo expansion using IL-21 with autologous feeder cells, and generation of anti-CD123-CAR-expressing effector cells. Hum Gene Ther. 28: 897–913.
Read paper

Köhl, U. et al. (2018) CAR T cells in trials: Recent achievements and challenges that remain in the production of modified T cells for clinical applications. Hum Gene Ther. 29: 559–568.
Read paper

Lock, D. et al. (2017) Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use. Hum Gene Ther 28(10): 914–925.
Read paper

Priesner, C. et al. (2016) Automated enrichment, transduction and expansion of clinical-scale CD62L+ T cells for manufacturing of GTMPs. Hum Gene Ther. 27: 860–869.
Read paper

Schmidt, P. et al. (2011) Eradication of melanomas by targeted elimination of a minor subset of tumor cells. Proceedings of the National Academy of Sciences of the United States of America 108: 2474–2479.
Read paper

Theurich, S. et al. (2016) Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma. Cancer Immunol Res 4(9): 744–54.
Read paper

Tischer, S. et al. (2014) Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells. Journal of translational medicine 12: 336.
Read paper

Zhu, F. et al. (2017) Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center. Cytotherapy 20(3): 394–406.
Read paper

Zuther, K. et al. (2017) Individualisierte Therapie mit CAR-exprimierenden Immunzellen. Journal Onkologie 2

Schlaak, M. et al. (2012) Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells. Oncotarget 3: 22–30.
Read paper